Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
02/26/2015 | US20150057186 Phage display using cotranslational translocation of fusion polypeptides |
02/26/2015 | US20150057164 High throughput methods for functionally determining rna interference efficiency |
02/26/2015 | US20150057155 Hybrid caulimovirus promoters and constructs thereof |
02/26/2015 | US20150056707 Engineering salt tolerance in photosynthetic microorganisms |
02/26/2015 | US20150056706 Vector |
02/26/2015 | US20150056705 Methods and compositions for treatment of a genetic condition |
02/26/2015 | US20150056704 Methods and products for biasing cellular development |
02/26/2015 | US20150056684 Methods, systems, and compositions for increased microorganism tolerance to and production of 3-hydroxypropionic acid (3-hp) |
02/26/2015 | US20150056669 Acetyl-coa carboxylases |
02/26/2015 | US20150056666 Variants of the promoter of the gap gene coding for glyceraldehyde-3-phosphate dehydrogenase |
02/26/2015 | US20150056655 Expression constructs and methods for expressing polypeptides in eukaryotic cells |
02/26/2015 | US20150056630 Dna controlling mir-140 expression, and screening method of drugs using said dna |
02/26/2015 | US20150056624 Method for isolating nucleic acids from a food sample |
02/26/2015 | US20150056251 Aav-directed persistent expression of an anti-nicotine antibody gene for smoking cessation |
02/26/2015 | US20150056246 Subunit vaccine delivery platform for robust humoral and cellular immune responses |
02/26/2015 | US20150056235 Materials and methods for respiratory disease control in canines |
02/26/2015 | US20150056232 Recombinant bacterium for induction of cellular immune response |
02/26/2015 | US20150056227 Priming of an immune response |
02/26/2015 | US20150056226 Immunotherapeutic agent |
02/26/2015 | US20150056215 Methods of treating proliferative disorders with malate or derivatives thereof |
02/26/2015 | US20150056207 Combination therapy with c-met and egfr antagonists |
02/26/2015 | US20150056177 Engineered transcription activator-like effector (tale) domains and uses thereof |
02/26/2015 | US20150056174 Self-cleaving ribozymes and uses thereof |
02/26/2015 | US20150056172 Methods and compositions using fgf-8 to enhance cardiac regeneration and attenuate adverse cardiac remodeling |
02/26/2015 | US20150056168 Bacterial expression system |
02/26/2015 | US20150056158 Branched polymers |
02/26/2015 | US20150056145 Magnetic nanoparticle-samirna complex and method for preparing same |
02/25/2015 | EP2840147A1 Method for assessing endometrial cancer susceptibility |
02/25/2015 | EP2840142A1 Genes and uses for plant enhancement |
02/25/2015 | EP2840141A1 Gene implicated in abiotic stress tolerance and growth accelerating and use thereof |
02/25/2015 | EP2840140A1 Crispr-Cas component systems, methods and compositions for sequence manipulation |
02/25/2015 | EP2840139A1 Method for the single step introduction of a plurality of genes in microbial cells |
02/25/2015 | EP2840138A2 Process for production of cis-4-hydroxy-L-proline |
02/25/2015 | EP2840137A1 Method for identification and detection of mutant gene using intercalator |
02/25/2015 | EP2840136A1 Method for detecting dna having microsatellite region |
02/25/2015 | EP2840130A1 Dna analysis micro-channel chip |
02/25/2015 | EP2840129A1 Dna analysis micro-channel chip |
02/25/2015 | EP2839840A1 Recombinant trivalent vaccine against human influenza |
02/25/2015 | EP2839281A1 Compositions and methods for identifying and diagnosing salt sensitivity of blood pressure |
02/25/2015 | EP2839037A1 Biomarkers to identify patients that will respond to treatment and treating such patients |
02/25/2015 | EP2839032A1 Detection of extracellular jcv micrornas |
02/25/2015 | EP2839031A1 Detection of target nucleic acid sequence by pto cleavage and extension-dependent signaling oligonucleotide cleavage |
02/25/2015 | EP2839016A1 Cell transfection method |
02/25/2015 | EP2839015A1 Lipidated glycosaminoglycan particles for the delivery of nucleic acids |
02/25/2015 | EP2839014A1 Composition and methods for highly efficient gene transfer using aav capsid variants |
02/25/2015 | EP2839013A2 Non-disruptive gene targeting |
02/25/2015 | EP2839012A1 Method for increasing the secretion of recombinant proteins |
02/25/2015 | EP2839011A1 Method for the expression of polypeptides using modified nucleic acids |
02/25/2015 | EP2839010A1 Method of producing a recombinant peptide |
02/25/2015 | EP2839009A1 Generating targeted sequence diversity in proteins |
02/25/2015 | EP2839008A2 Compositions and methods for modulation of atxn3 expression |
02/25/2015 | EP2839007A1 Methods for increasing cotton fiber length |
02/25/2015 | EP2839006A2 Oligomeric compounds comprising bicyclic nucleotides and uses thereof |
02/25/2015 | EP2839005A2 Mirna modulators of thermogenesis |
02/25/2015 | EP2839004A1 Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation |
02/25/2015 | EP2839003A1 Reduction of formation of amidated amino acids in cell lines for protein expression |
02/25/2015 | EP2839002A2 Compositions comprising an internalizing nucleic acid molecule, and their methods of use |
02/25/2015 | EP2839001A1 Means and methods for generating improved proteins |
02/25/2015 | EP2838990A1 Recombinant mycobacterium encoding a heparin-binding hemagglutinin (hbha) fusion protein and uses thereof |
02/25/2015 | EP2838919A1 Anti-mige antibodies that bind to the junction between ch4 and c epsilon mx domains |
02/25/2015 | EP2838912A1 Peptides for the binding of nucleotide targets |
02/25/2015 | EP2838910A1 Replication-competent vesicular stomatitis viruses |
02/25/2015 | EP2838567A1 Tfeb gene therapy of alpha-1-antitrypsin deficiency |
02/25/2015 | EP2838548A1 Hla class ii deficient cells, hla class i deficient cells capable of expressing hla class ii proteins, and uses thereof |
02/25/2015 | EP2838542A2 Methods and pharmaceutical compositions for the treatment of hypertension |
02/25/2015 | EP2838541A1 Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies |
02/25/2015 | EP2838346A1 Thrips resistant cabbage |
02/25/2015 | EP2838345A1 Solanum lycopersicum plants having non-transgenic alterations in the rin gene |
02/24/2015 | US8962953 Plants and seeds of corn variety CV102577 |
02/24/2015 | US8962951 Plants and seeds of hybrid corn variety CH344455 |
02/24/2015 | US8962950 Plants and seeds of hybrid corn variety CH796501 |
02/24/2015 | US8962948 Maize variety inbred PH1DDK |
02/24/2015 | US8962947 Transcription factors |
02/24/2015 | US8962942 Soybean cultivar 18040631 |
02/24/2015 | US8962941 Soybean cultivar S100237 |
02/24/2015 | US8962940 Soybean variety XBP18006 |
02/24/2015 | US8962939 Soybean variety XR33S13 |
02/24/2015 | US8962938 Soybean variety XB05A13 |
02/24/2015 | US8962937 Soybean cultivar 10221117 |
02/24/2015 | US8962936 Soybean cultivar S110245 |
02/24/2015 | US8962935 Soybean cultivar 11251426 |
02/24/2015 | US8962934 Soybean cultivar XB33J12 |
02/24/2015 | US8962933 Soybean variety A1037459 |
02/24/2015 | US8962932 Melon hybrid SV0331MV and parents thereof |
02/24/2015 | US8962926 Pea line EX 08570957 |
02/24/2015 | US8962925 Marchantiales-derived unsaturated fatty acid synthetase genes and use of the same |
02/24/2015 | US8962923 Hybrid carrot variety NUN 89141 CAC |
02/24/2015 | US8962922 Spinach hybrid SV3580VC |
02/24/2015 | US8962921 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
02/24/2015 | US8962920 Use of active cytokinin synthase gene |
02/24/2015 | US8962919 Method for enhancing thermotolerance of plant relating to exportin1A and genetic engineering applications thereof |
02/24/2015 | US8962918 Polynucleotide sequence of fruit softening associated A-mannosidase and its uses for enhancing fruit shelf life |
02/24/2015 | US8962917 Delta-5 desaturase and its use in making polyunsaturated fatty acids |
02/24/2015 | US8962916 Viral promoter, truncations thereof, and methods of use |
02/24/2015 | US8962915 Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same |
02/24/2015 | US8962913 Humanized IL-7 rodents |
02/24/2015 | US8962912 Transgenic non-human animals expressing human blood clotting factors and uses thereof |
02/24/2015 | US8962819 Anti-C5 alpha antibodies |
02/24/2015 | US8962816 Constructs for enhancing immune responses |
02/24/2015 | US8962811 Growth hormone and interferon-alpha 2 glycoproteins produced in plants |